
On July 1, 2026, the landscape of obesity care will change significantly with the launch of the Medicare GLP-1 Bridge program. This program introduces a brand-new, affordable pathway for eligible Medicare beneficiaries to access modern obesity treatments.
However, with nationwide awareness currently low, medical providers and pharmacists must lead the way. Patient access depends entirely on whether clinical teams understand how to navigate this new model ahead of launch day.
Join the Obesity Care Advocacy Network (OCAN) and our co-sponsors—the American Diabetes Association (ADA), Obesity Action Coalition (OAC), Obesity Medicine Association (OMA), American Society for Metabolic and Bariatric Surgery (ASMBS), and The Obesity Society (TOS)—for an essential national briefing, a rebroadcast of the expert presentations by the following panelists, on the new Medicare Bridge program.

The Route: How to identify eligible patients using specific BMI and comorbidity thresholds.
The Rules: How to navigate the brand-new CMS prior authorization process and billing pathways.
The Conversation: Practical and informative communication strategies to empower patients to take the first step.

